论文信息 - First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study - 字舞流文

First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study

K. Naoki | Takashi Sato | S. Igawa | J. Sasaki | T. Fukui | Masashi Kasajima | Y. Nakahara | Takahiro Ozawa | Seiichiro Kusuhara | M. Kakegawa | T. Ono | Mitsufuji Hisashi